Kwality Pharmaceuticals LtdBSE: KPL

Kwality Pharmaceuticals Ltd Press Release Nov 26 2024

Nov 26, 2024 at 12:53 AM EST · Issued by Kwality Pharmaceuticals Ltd via BSE India

Filed with BSE · Nov 26, 2024 at 12:53 AM EST

Kwality received its first Biological Product Permission for Manufacturing and Sale of PEGylated - Asparaginase

6ix hasn’t read this filing yet.

Later from Kwality Pharmaceuticals

Follow Kwality Pharmaceuticals into a list and get an email when it puts out news.